Phio Pharmaceuticals Corp. (PHIO)

CIK 1533040 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Phio Pharmaceuticals Corp..

Recent SEC filings

FiledFormAccession number
Aug 20, 202640001683168-26-006620
Aug 19, 202640001683168-26-006592
Aug 14, 2026ARS0001683168-26-006475
Aug 14, 2026DEF 14A0001437749-26-027997
Aug 14, 2026DEFA14A0001683168-26-006474
Aug 6, 202610-Q0001437749-26-026271
Aug 6, 20268-K0001437749-26-026275
Jul 30, 202630001683168-26-005842
Jul 21, 20268-K0001437749-26-023916
Jun 29, 202640001683168-26-005164
May 7, 20268-K0001437749-26-015590
May 7, 202610-Q0001437749-26-015604
Apr 8, 2026424B50001683168-26-002750
Apr 8, 20268-K0001437749-26-011761
Mar 30, 20268-K0001437749-26-010164
Mar 5, 202610-K0001437749-26-007078
Mar 5, 20268-K0001437749-26-007071
Feb 18, 20268-K0001437749-26-004542
Feb 17, 2026SCHEDULE 13G/A0001649553-26-000030
Feb 13, 2026SCHEDULE 13G/A0001213900-26-016522
Feb 10, 20268-K0001437749-26-003575
Feb 6, 202640001683168-26-000809
Feb 6, 202640001683168-26-000813
Feb 6, 202640001683168-26-000811
Feb 6, 202640001683168-26-000803